Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Jakubik, D; Fitas, A; Eyileten, C; Jarosz-Popek, J; Nowak, A; Czajka, P; Wicik, Z; Sourij, H; Siller-Matula, JM; De Rosa, S; Postula, M.
MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
Cardiovasc Diabetol. 2021; 20(1): 55-55. Doi: 10.1186/s12933-021-01245-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Sourij Harald

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

The epidemic of diabetes mellitus (DM) necessitates the development of novel therapeutic and preventative strategies to attenuate complications of this debilitating disease. Diabetic cardiomyopathy (DCM) is a frequent disorder affecting individuals diagnosed with DM characterized by left ventricular hypertrophy, diastolic and systolic dysfunction and myocardial fibrosis in the absence of other heart diseases. Progression of DCM is associated with impaired cardiac insulin metabolic signaling, increased oxidative stress, impaired mitochondrial and cardiomyocyte calcium metabolism, and inflammation. Various non-coding RNAs, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), as well as their target genes are implicated in the complex pathophysiology of DCM. It has been demonstrated that miRNAs and lncRNAs play an important role in maintaining homeostasis through regulation of multiple genes, thus they attract substantial scientific interest as biomarkers for diagnosis, prognosis and as a potential therapeutic strategy in DM complications. This article will review the different miRNAs and lncRNA studied in the context of DM, including type 1 and type 2 diabetes and the contribution of pathophysiological mechanisms including inflammatory response, oxidative stress, apoptosis, hypertrophy and fibrosis to the development of DCM .

Find related publications in this database (Keywords)

miRNA

LncRNA

Diabetes mellitus type 2

Diabetic cardiomyopathy

Inflammation

Oxidative stress

Novel biomarker

Novel treatment

Novel therapy

© Med Uni Graz • Imprint